C57BL/6JGpt DIO 60%
Mouse Model: B6 DIO RD
Strain Number: T002040
Inbred strain
- Product Type:
- Quantity: - +
- Sex:
- Age:
- Genotype:
GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library
With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.
| Strain Name: | C57BL/6JGpt DIO 60% |
| Strain Number: | T002040 |
| Official Symbol: | / |
| Strain Strategy: | T002040.B6 DIO RD strain info.pdf |
| NCBI Number: | / |
| Research Areas: | Disease Models,Metabolic Disease,Obesity model |
| Strain Background: | [N000013] C57BL/6JGpt |
| Modification Type: | Inbred strain |
| Inventory Status: | Live |
| Sale Status: | IF (Available for Distribution) |
| Health Status: | Specific pathogen free (SPF) |
| Publications: | 1. Single-Cell RNA-seq Analysis Reveals a Positive Correlation between Ferroptosis and Beta-Cell Dedifferentiation in Type 2 Diabetes. Biomedicines (2024)2. Effect of chitooligosaccharides on human gut microbiota and antiglycation. Carbohydrate polymers (2020)3. The human-derived novel gut commensal Luoshenia tenuis regulates body weight and food intake in mice. Food Science and Human Wellness (2023) |
Extend the Value of Your Mouse Models with Integrated Preclinical Services
GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.